Skip to main content
. 2021 Mar 24;124(11):1795–1802. doi: 10.1038/s41416-021-01284-2

Fig. 3. RCB 0/1 rate and pCR rate in patients with conventional and reverse chemotherapy sequence with or without L-BLP25.

Fig. 3

RCB residual cancer burden, pCR pathologic complete remission. With vs. without L-BLP25 (a) conventional chemotherapy patients and RCB 0/I rate, (b) reverse chemotherapy patients and RCB 0/I rate, (c) conventional chemotherapy patients and pCR rate, (d) reverse chemotherapy patients and pCR rate.